Book contents
- Frontmatter
- Contents
- List of contributors
- Acknowledgements
- Introduction: revision of an old transmitter
- Part I The neurobiology of norepinephrine
- Part II Norepinephrine and behavior
- Part III The biology of norepinephrine in CNS pathology
- 10 Animal models of psychopathology: focus on norepinephrine
- 11 Neuropathology of central norepinephrine in psychiatric disorders: postmortem research
- 12 Norepinephrine in mood disorders
- 13 Noradrenergic pathology and pain
- 14 Norepinephrine and cognitive disorders
- 15 Norepinephrine in neurological disorders
- 16 Genetics of noradrenergic neurobiology
- Part IV Psychopharmacology of norepinephrine
- Index
11 - Neuropathology of central norepinephrine in psychiatric disorders: postmortem research
from Part III - The biology of norepinephrine in CNS pathology
Published online by Cambridge University Press: 07 September 2009
- Frontmatter
- Contents
- List of contributors
- Acknowledgements
- Introduction: revision of an old transmitter
- Part I The neurobiology of norepinephrine
- Part II Norepinephrine and behavior
- Part III The biology of norepinephrine in CNS pathology
- 10 Animal models of psychopathology: focus on norepinephrine
- 11 Neuropathology of central norepinephrine in psychiatric disorders: postmortem research
- 12 Norepinephrine in mood disorders
- 13 Noradrenergic pathology and pain
- 14 Norepinephrine and cognitive disorders
- 15 Norepinephrine in neurological disorders
- 16 Genetics of noradrenergic neurobiology
- Part IV Psychopharmacology of norepinephrine
- Index
Summary
The postmortem human brain as a tool to study central nervous system disease
Abnormalities in noradrenergic transmission are likely to play a role in behavioral expressions of a number of psychiatric and neurological disorders. The extent to which these abnormalities are pathognomonic, or even principal pathological features contributing to the illness, remains debatable. Interest in the potential for pathological abnormalities in central norepinephrine in central nervous system (CNS) disorders derives from the three general observations: (1) disruption of behaviors known to be heavily influenced by noradrenergic transmission that are associated with the illness; (2) demonstration that pharmacological manipulation of noradrenergic transmission can precipitate, modify, or alleviate symptoms of these disorders; and (3) certain CNS disorders are characterized pathologically by a loss of noradrenergic neurons in the brain. Research on the pathology of central noradrenergic systems in CNS diseases and their relationship to behavioral alterations utilizes a variety of techniques, most of which are technically indirect, given that we currently are unable to directly measure noradrenergic neuron activity, noradrenergic receptor signaling, or norepinephrine release in vivo in living humans. In vivo imaging methods now permit investigators to measure occupancy of certain receptors, but application of these methods specifically to noradrenergic proteins, such as receptors, enzymes or transporters, has been limited.
One method to study the role of norepinephrine in the CNS disorders is to utilize postmortem brain tissue from subjects with a given psychiatric or neurological condition.
- Type
- Chapter
- Information
- Brain NorepinephrineNeurobiology and Therapeutics, pp. 341 - 362Publisher: Cambridge University PressPrint publication year: 2007
- 6
- Cited by